FDA Updates
Published: 03/30/2022
Sources:
- Food and Drug Administration
Relevant To:
- All Healthcare Organizations
The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities:
- FDA Limits Use of Sotrovimab to Treat COVID-19 in Additional U.S. Regions Due to the BA.2 Omicron Sub-Variant
- Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter
- FDA Recommends Thyroid Monitoring in Babies and Young Children Who Receive Injections of Iodine-Containing Contrast Media for …